ReviewDialogues in clinical neuroscience2008
The effectiveness of anticonvulsants in psychiatric disorders.
Review in Dialogues in clinical neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 54 citations in OpenAlex.
- A prospective pilot study of levetiracetam for body dysmorphic disorder.CNS spectrums · 2009Trial
- Management of Treatment-Resistant Depression: An Updated Narrative Review of Current and Emerging Treatments.Cureus · 2026Review
- Novel Dual 5-HTPharmaceuticals (Basel, Switzerland) · 2025Article
- Drugs with glutamate-based mechanisms of action in psychiatry.Pharmacological reports : PR · 2024Review
- Lack of Efficacy of Simvastatin Adjunctive Therapy for Patients with Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.Neuropsychiatric disease and treatment · 2024Article
- DrugResearch and practice in thrombosis and haemostasis · 2023Review
- Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals.BMC medical informatics and decision making · 2022Article
- Current and Possible Future Therapeutic Options for Huntington's Disease.Journal of central nervous system disease · 2022Review
- Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review).Molecular medicine reports · 2021Review
- Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review.Therapeutic advances in psychopharmacology · 2021Review
- Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation.Therapeutic advances in psychopharmacology · 2018Review
- Teratogenic risk and contraceptive counselling in psychiatric practice: analysis of anticonvulsant therapy.BMC psychiatry · 2013Article
- Brief report: retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism spectrum disorder.Journal of autism and developmental disorders · 2013Article
- Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice.Psychopharmacology · 2009Article
- Delirium: sifting through the confusion.Current psychiatry reports · 2009Review
- A Drosophila systems model of pentylenetetrazole induced locomotor plasticity responsive to antiepileptic drugs.BMC systems biology · 2009Article
- Outpatient Treatment of Tic Disorders Among Children and Adults.Movement disorders clinical practiceArticle
- The Therapeutic Effects of Low-Frequency Electrical Stimulations Adjunct to Sodium Valproate on Seizure and Behaviors.Basic and clinical neuroscienceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anticonvulsant drugs are widely used in psychiatric indications. These include mainly alcohol and benzodiazepine withdrawal syndromes, panic and anxiety disorders, dementia, schizophrenia, affective disorders, bipolar affective disorders in particular, and, to some extent, personality disorders. A further area in which neurology and psychiatry overlap is pain conditions, in which some anticonvulsants, and also typical psychiatric medications such as antidepressants, are helpful. From the beginning of their psychiatric use, anticonvulsants have also been used to ameliorate specific symptoms of psychiatric disorders independently of their causality and underlying illness, eg, aggression, and, more recently, cognitive impairment, as seen in affective disorders and schizophrenia. With new anticonvulsants currently under development, it is likely that their use in psychiatry will further increase, and that psychiatrists need to learn about their differential efficacy and safety profiles to the same extent as do neurologists.
Indexed as
Identifiers
18472486PMC3181858W182612897What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.